DAWN CH Newsletters 2014

November 2014

Support Desk Holiday Closures
DAWN CH Key Product Updates
Logging out of DAWN Correctly
Dana-Farber, Brigham and Women’s Develop NGS Panel for Rapid Diagnosis of Hematologic Cancers
Researchers discover new target for blood cancer treatment
UK’s NICE recommends GSK’s Arzerra for untreated chronic lymphocytic leukemia

October 2014

The importance of backups
Server/PC upgrades and replacements – best practice
Do you have the new ‘View Button’?
Oral therapies shift treatment paradigm in CLL
New research to beat blood cancers
Pharmacyclics’ Imbruvica gets European approval to treat two blood cancers

September 2014

Seamless Integration with Healthcare Systems
How do you score toxicity?
DAWN as a disease registry for haematology disorders
Combination of ibrutinib, rituximab induced responses in high-risk CLL
European Commission Grants Marketing Authorization for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma

August 2014

Communications – Letters / Faxes / e-mails
Work Smarter – Latest Version 7.9.39
Boost team work with electronic referrals
Demographics Interface – Best Practice
Ibrutinib and Idelalisib Coming to Europe Soon
Octapharma gets FDA approval for immune thrombocytopenic purpura therapy Octagam 10%

July 2014

DAWN User Group Workshop Summary
Patient summary ‘View’ button introduced in 7.9.36
FREE Online customer training
Use DAWN questionnaires to calculate scores
Leukaemia prognosis test developed at Cardiff University
European Commission grants marketing approval for GSK and Genmab’s Arzerra
Biochemical cascade causes bone marrow inflammation, leading to serious blood disorders

June 2014

DAWN User Workshop
Work Smarter – Latest version now available
Logging out of DAWN correctly
Mechanisms of ibrutinib resistance identified in chronic lymphocytic leukemia
Combined lenalidomide and rituximab dose escalation found to be safe for CLL
Microenvironment of hematopoietic stem cells can be a target for myeloproliferative disorders

May 2014

Work Smarter – Latest Release
How do you score toxicity?
Boost team work with electronic referrals
DAWN as a disease registry for haematology disorders
Download the latest DAWN CH Brochure
A pill may provide hope to relapsed leukemia and lymphoma patients
Drug to fight leukemia in sight, say Australian researchers

April 2014

BSH 2014 – Thank You
Time is running out – Book your place at our online user workshop!
Work Smarter – Latest Release
Demographics Interface – Best Practice
Half of UK Cancer Patients Now Survive for 10 Years or More
New drug for patients with leukaemia and lymphoma puts an end to chemotherapy
Scientists receive $2.3M grant to develop new technology to diagnose cancer, rheumatoid arthritis and colitis

March 2014

DAWN CH facilitates nurse-led haematology clinics at NHS Lanarkshire
DAWN gets smarter, easier, quicker
Come and see us at the BSH Meeting 2014
Have you visited the new 4S DAWN website yet?
DAWN CH Clinical Haematology brochure
Dartmouth researchers develop unique approach to treat Chronic Lymphocytic Leukemia
Obinutuzumab Beats Rituximab in CLL
Carbohydrates serve as identifiers for cancer cells

February 2014

Come and see us at the BSH Meeting
DAWN questionnaires available to calculate scores
Print directly from DAWN for administration efficiencies
DAWN CH Clinical Haematology Brochure
Leukemia pill ‘can melt away’ cancer cells
Ibrutinib (Imbruvica) Approved for CLL in US

January 2014

Easy access to the help manual and login improvements
Common Safety Concerns to Look out For!
Reporting in DAWN CH
Use DAWN CH as the key patient record in your department
NEW DAWN CH Clinical Haematology Brochure
New gene mutation found in Myeloproliferative Neoplasms
Erythropoietin and the regulation of cancer stem cell growth and survival